During the past 12 months, Maravai LifeSciences Holdings's average Revenue per Share Growth Rate was -14.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -15.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -9.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Maravai LifeSciences Holdings was 30.60% per year. The lowest was -39.40% per year. And the median was 6.80% per year.
Competitive Comparison of Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate
For the Biotechnology subindustry, Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Maravai LifeSciences Holdings 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MRVI has been successfully added to your